4 recent spine, orthopedic studies to know

Becker’s reported on four key spine and orthopedic studies during the third quarter of 2023:

Advertisement

1. Relievant Medsystems shared four-year results from two clinical trials demonstrating the safety, effectiveness and durability of its Intracept procedure for patients with vertebrogenic pain. 

2. Researchers with New York City-based Hospital for Special Surgery found the combination of oral ketamine and aspirin is a safe form of pain medication after total knee replacement.

3. Spinal Simplicity’s Minuteman spinal fusion device was found to be safe and effective in a real-world setting, according to a study published in The Journal of Pain Research.

4. Researchers at New York City-based Hospital for Special Surgery and Weill Cornell Medicine discovered a new stem cell that could affect spine care. The findings, published in Nature, uncovered vetebral stem cells that are uniquely present in the spine.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement

Comments are closed.